๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Neoadjuvant Chemotherapy
Clinical trial register · China

Neoadjuvant Chemotherapy Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 6 Shanghai 2 Hangzhou 2 Beijing 1 Wuxi 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou6 Shanghai2 Hangzhou2 Beijing1 Wuxi1
All 8 locations
Target enrolment
to

Neoadjuvant Chemotherapy trials in China

13 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer
NCT07596472Breast Cancer, Axillary Lymph Node Metastasis, Neoadjuvant Chemotherapy, Pathological Complete Response
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
150
Guangzhou
2026-05-20
Recruiting
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
NCT06998758Neoadjuvant Chemotherapy, Weight Loss
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
60
Guangzhou
2025-11-11
Not yet open
Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients
NCT07142863Osteosarcoma, Neoadjuvant Therapy, Neoadjuvant Chemotherapy, PD-L1 Antibody
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
23
Shanghai
2025-08-25
Not yet open
Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer
NCT07077018Fasting-Mimicking Diet, Breast Cancer, Neoadjuvant Chemotherapy
Guangdong Provincial People's Hospital
Not applicable
45
Guangzhou
2025-07-12
Recruiting
Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
NCT07051083Bladder Cancer, Staging, Deep Learning, Neoadjuvant Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
480
Guangzhou
2024-01-01
Recruiting
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer
NCT06155305Organoids, Breast Cancer, Neoadjuvant Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
58
Hangzhou
2023-12-06
Active, closed
Toripalimab-based Neoadjuvant Therapy in LA-HNSCC
NCT05522985Head and Neck Squamous Cell Carcinoma, Neoadjuvant Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Phase 2
122
Tianjin
2022-09-02
Recruiting
Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial
NCT05367206Cervical Cancer, Neoadjuvant Chemotherapy, Bulky Neoplasm
Sun Yat-sen University
Phase 3
280
Guangzhou
2022-03-14
Recruiting
Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
NCT05202314Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction
Beijing Chao Yang Hospital
Not applicable
20
Beijing
2021-12-12
Not yet open
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
NCT04384601Gastric Cancer, Neoadjuvant Chemotherapy
Ruijin Hospital
Phase 3
246
Shanghai
2021-09
Active, closed
Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer
NCT04922853Rectal Cancer, Neoadjuvant Chemotherapy
West China Hospital
Phase 3
554
Wuxi, Chengdu, Kunming
2021-08-26
Recruiting
Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer
NCT04576143HER2-negative Breast Cancer, Neoadjuvant Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2/3
260
Hangzhou
2020-09-20
Active, closed
ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
NCT04172259Breast Cancer, Neoadjuvant Chemotherapy
Sun Yat-sen University
Phase 2
156
Guangzhou
2019-01-10
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/neoadjuvant-chemotherapy

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Neoadjuvant Chemotherapy.

How many Neoadjuvant Chemotherapy trials are recruiting in China?

6 of the 13 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Neoadjuvant Chemotherapy), 13 studies
PhaseStudiesRecruitingShare
Phase 34230.8%
Observational3223.1%
Phase 23023.1%
Not applicable2115.4%
Phase 2/3117.7%

Most active sponsors

Lead sponsors with the most studies (Neoadjuvant Chemotherapy)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine22
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University21
Sun Yat-sen University21
Beijing Chao Yang Hospital11
Guangdong Provincial People's Hospital10
Ruijin Hospital10
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine10
Sixth Affiliated Hospital, Sun Yat-sen University11
Tianjin Medical University Cancer Institute and Hospital10
West China Hospital10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.